Axsome Therapeutics, Inc. (AXSM) Balance Sheet
As of 2026-06-30 (10-Q), Axsome Therapeutics, Inc. (AXSM) reported total assets of $761.4M, total liabilities of $678.1M and shareholders' equity of $83.3M, according to EquiReason's reading of its SEC filings. Cash and equivalents: $319.9M. Long-term debt: $118.0M.
Source: SEC EDGAR filings · figures as of 2026-06-30 · read by EquiReason
AXSMAxsome Therapeutics, Inc.Follow AXSM — free
—
Price chart with a free account
- Market cap
- 7.6B
- P/E TTM
- —
- Dividend yield
- —
- 52-week
- —
- Next earnings
- 2 Nov, in 8 days
| Line | FY2016 Dec 16 | FY2017 Dec 17 | FY2018 Dec 18 | FY2019 Dec 19 | FY2020 Dec 20 | FY2021 Dec 21 | FY2022 Dec 22 | FY2023 Dec 23 | FY2024 Dec 24 | FY2025 Dec 25 | Latest Jun 26 | Trend |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash and equivalents | — | — | — | 220.0 | 183.9 | 86.5 | 200.8 | 386.2 | 315.4 | 322.9 | 319.9 | |
| Receivables | — | — | — | — | — | — | 37.7 | 94.8 | 142.0 | 224.5 | 277.5 | |
| Inventory | — | — | — | — | — | — | 4.3 | 15.1 | 15.7 | 27.9 | 37.9 | |
| Current assets | 38.0 | 35.3 | 15.2 | 220.4 | 184.0 | 86.5 | 245.6 | 504.3 | 485.1 | 589.0 | 656.6 | |
| Total assets | 38.2 | 35.6 | 15.4 | 220.5 | 186.1 | 87.8 | 331.5 | 588.2 | 568.5 | 689.8 | 761.4 | |
| Current liabilities | 7.2 | 12.2 | 10.8 | 24.5 | 23.4 | 23.1 | 96.6 | 138.9 | 230.1 | 378.8 | 460.4 | |
| Long-term debt | 9.5 | 6.7 | 3.6 | 17.3 | 48.3 | 49.1 | 94.3 | 178.1 | 180.7 | 117.7 | 118.0 | |
| Short-term debt | 0.3 | 3.3 | 3.3 | 2.6 | — | — | — | — | 0.0 | 70.0 | 70.0 | |
| Total liabilities | 16.6 | 18.8 | 14.4 | 41.8 | 72.3 | 72.2 | 221.9 | 397.3 | 511.5 | 601.5 | 678.1 | |
| Shareholders' equity | 21.6 | 16.7 | 0.9 | 178.7 | 113.8 | 15.6 | 109.6 | 191.0 | 57.0 | 88.3 | 83.3 |
USD millions · SEC XBRL
Axsome Therapeutics, Inc. — questions
- How much cash does Axsome Therapeutics, Inc. have?
- $319.9M in cash and cash equivalents as of 2026-06-30.
- How much debt does Axsome Therapeutics, Inc. have?
- $118.0M of long-term debt and $70.0M due within a year as of 2026-06-30.
- What are Axsome Therapeutics, Inc.'s total assets?
- $761.4M as of 2026-06-30.
- What is Axsome Therapeutics, Inc.'s shareholders' equity?
- $83.3M as of 2026-06-30.
Every figure on this page comes from Axsome Therapeutics, Inc.'s own SEC filings — see them on SEC EDGAR. Price data is licensed and shown only inside the product.
How these figures are read: methodology · EquiReason.